Printer Friendly

Hopkins creates $65M research agreement with Deerfield.

Byline: Tim Curtis

Johns Hopkins University and Deerfield Management will collaborate on a $65 million research initiative to develop early stage therapeutics. The collaboration, Bluefield Innovations, will over five years support the commercialization of early-stage therapeutic research conducted at Hopkins. Additional funding will be available for research that has a strong commercial potential.Bluefield will focus broadly on therapeutics, including the areas of oncology, neurology and pain. Deerfield, an investment management firm, will provide the funding. A joint steering committee will pick Bluefield's research and guide the development process. That process will include basic research, proof of concept and target selection. It will also include investigational studies to determine candidates to enter into human clinical trials. Research from Bluefield will be licensed to third parties or spun out as new companies.

Copyright 2017 BridgeTower Media. All Rights Reserved.

COPYRIGHT 2017 BridgeTower Media Holding Company, LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Daily Record (Baltimore, MD)
Date:Nov 16, 2017
Words:138
Previous Article:Violence is out of control and a call to action.
Next Article:Editorial Advisory Board: Lets put a little steel in saying we want better access to justice.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters